With deal to close this week, Bayer to
retire Monsanto name
Send a link to a friend
[June 04, 2018]
By Ludwig Burger
FRANKFURT (Reuters) - Germany's Bayer
<BAYGn.DE> will wrap up the $63 billion takeover of Monsanto <MON.N> on
Thursday and also retire the U.S. seeds maker's 117 year-old name.
The German drugmaker had received all required approvals from regulatory
authorities, it said in a statement on Monday.
"Bayer will remain the company name. Monsanto will no longer be a
company name. The acquired products will retain their brand names and
become part of the Bayer portfolio," it said.
Bayer launched a 6 billion euro ($7 billion) rights issue on Sunday, a
cornerstone of the financing package for the deal, shortly after
clearing the last major antitrust hurdle in the United States.
The deal is the first of a trio of major U.S.-German merger deals to
cross the finish line at a time of harsh criticism by U.S. President
Donald Trump of Germany's trade surplus with the United States.
Deutsche Telekom's <DTEGn.DE> T-Mobile US <TMUS.O> plans to merge with
Sprint for $26 billion, while industrial gases makers Linde <LING.DE>
and Praxair <PX.N> are also seeking to combine.
Bayer was expected to rid itself of the target's name. Monsanto, the
largest - though not the only - maker of genetically modified seeds, has
been a lightning rod for environmentalists' opposition to the
technology.
[to top of second column]
|
Werner Baumann, CEO of German pharmaceutical and chemical maker
Bayer AG, reacts as he attends the annual general shareholders
meeting in Bonn, Germany, May 25, 2018. REUTERS/Wolfgang Rattay/File
Photo
The U.S. seed maker has also drawn criticism for pursuing its
intellectual property rights with farmers, many of which depend on
its seeds, more aggressively than its peers.
"We aim to deepen our dialogue with society. We will listen to our
critics and work together where we find common ground. Agriculture
is too important to allow ideological differences to bring progress
to a standstill," Bayer Chief Executive Werner Baumann said in the
statement.
The companies' separately listed Indian units, Bayer CropScience
Ltd. <BAYE.NS> and Monsanto India Ltd. <MNSN.NS>, will continue to
operate independently for the time being, Bayer said in a separate
statement.
(Reporting by Ludwig Burger; Editing by Maria Sheahan/Keith Weir)
[© 2018 Thomson Reuters. All rights
reserved.]
Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|